The CEO of U.S.-based pharmaceutical and biotechnology company Moderna said he hopes for a booster shot for its two-dose COVID-19 vaccine to become available in the fall. Stéphane Bancel made the announcement during an interview with CNBC’s “Squawk Box” on Wednesday, saying the company is working towards the booster shot in case it will be needed against emerging variants of the CCP (Chinese Communist Party) virus—which causes the disease COVID-19. “I anticipate in the next year or so, we’re going to see a lot of variants,” Bancel said. “But as more and more people get vaccinated or naturally infected, the pace of the variant is going to slow down and the virus is going to stabilize like you see with flu.” “I want to make sure there are boost vaccines available in the fall so that we protect people as we go into the next fall and winter season in the U.S.,” …